SITC Champions

The goal of the SITC Champions program is to address the need for community education about immunotherapy, as well as disseminate information and build awareness for SITC’s educational programming and initiatives to institutions and companies across the globe. The SITC Membership Committee implemented the SITC Champion initiative to encourage two-way communication between the Society and institutions throughout the country.

SITC Champions receive recognition from the Society and the cancer immunotherapy community, have networking opportunities with other SITC Champions at top institutions, and the opportunity to further the field of cancer immunotherapy.

To learn more about becoming a SITC Champion, please contact SITC Director of Membership, Nichole Nikolic, at  NNikolic@sitcancer.org or 1-414-271-2456.

 

Members

Sylvia Adams, MD
NYU Cancer Institute

Richard B. Alexander, MD
University of Maryland School of Medicine 

Simo Arredouani, PhD
Agenus, Inc.          

Michael B. Atkins, MD
Georgetown-Lombardi Comprehensive Cancer Center

Shailender Bhatia, MD
University of Washington     

Hossein Borghaei, MS, DO
Fox Chase Cancer Center       

Christine Brown, PhD
City of Hope National Medical Center

Timothy NJ Bullock, PhD
University of Virginia

Marcus O. Butler, MD
Princess Margaret Hospital/Ontario Cancer Institute

Robert Canter, MD, MAS, FACS
UC Davis Health System

William Carson, III, MD, FACS
The Ohio State University                

Daniel S. Chen, MD, PhD
Genentech

Laurence J.N. Cooper, MD, PhD
MD Anderson Cancer Center   

Marc S. Ernstoff, MD
Roswell Park Cancer Institute

Robert L. Ferris, MD, PhD
University of Pittsburgh Cancer Institute         

Robert A. Figlin, MD, FACP
Cedars-Sinai Medical Center

James H. Finke, PhD
Cleveland Clinic Foundation     

Lawrence Fong, MD
University of California, San Francisco

Dmitry I. Gabrilovich, MD, PhD
The Wistar Institute       

Thomas F. Gajewski, MD, PhD
University of Chicago                

Charlie Garnett Benson, PhD
Georgia State University                       

Michael P. Gustafson, PhD
Mayo Clinic

Raquibul Hannan, MD, PhD
University of Texas Southwestern Medical Center  

John P. Hanson, Jr., MD
JPH Foundation for Cancer Research Inc.

F. Stephen Hodi, Jr., MD
Dana-Farber Cancer Institute              

Jing-Zhou Hou, MD PhD
University of Pittsburgh Medical Center                        

Carl H. June, MD
University of Pennsylvania                    

Howard L. Kaufman, MD, FACS
Rutgers Cancer Institute of New Jersey

Steven C. Katz, MD
Roger Williams Medical Center       

Keith L. Knutson, PhD
Mayo Clinic Jacksonville          

Holbrook E. Kohrt, MD, PhD*
Stanford Cancer Institute  

David H. Lawson, MD
Winship Cancer Institute of Emory University 

Sylvia Lee, MD
Fred Hutchinson Cancer Research Center  

Gregory P. Lesinski, PhD, MPH
The Ohio State University

Ronald Levy, MD
Stanford University School of Medicine  

Jianqing Lin, MD
Thomas Jefferson University     

Theodore F. Logan, MD
Indiana University Simon Cancer Center                      

H. Kim Lyerly, MD
Duke University Medical Center  

Michele Maio, MD, PhD
Azienda Ospedalieria Senese  

Masoud Manjili, DVM, PhD
Virginia Commonwealth University             

Francesco M. Marincola, MD
Sidra Medical and Research Center     

Marcela V. Maus, MD, PhD
Massachusetts General Hospital

James J. Mule, PhD
Moffitt Cancer Center  

Smita Nair, PhD
Duke University Medical Center                       

Pamela S. Ohashi, PhD
Princess Margaret Cancer Centre               

Russell Pachynski, MD
Washington University School of Medicine

A. Karolina Palucka, MD, PhD
The Jackson Laboratory for Genomic Medicine

Drew M. Pardoll, MD, PhD
Johns Hopkins University

Sandip Patel, MD
UCSD Moores Cancer Center

Chrystal M. Paulos, PhD
Medical University of South Carolina

Daniel J. Powell Jr., PhD
University of Pennsylvania    

Igor Puzanov, MD, MSCI, FACP
Vanderbilt University         

William L. Redmond, PhD
Earle A. Chiles Research Institute

Cliona M. Rooney, PhD
Baylor College of Medicine

Senthamil R. Selvan, PhD
Omni Array Biotechnology   

Kimberly A. Shafer-Weaver, PhD
AstraZeneca       

Anil Shanker, PhD
Meharry Medical College / Vanderbilt-Ingram Comprehensive Cancer Center                 

Paul M. Sondel, MD, PhD
University of Wisconsin - Madison                  

Mario Sznol, MD
Yale University School of Medicine                    

James E. Talmadge, PhD
University of Nebraska Medical Center            

Walter J. Urba, MD, PhD
Earle A. Chiles Research Institute / Providence Cancer Center    

Robert W. Wilkinson, PhD
MedImmune

Jedd D. Wolchok, MD, PhD
Memorial Sloan Kettering Cancer Center 

Laura S. Wood, RN, MSN, OCN
Cleveland Clinic Taussig Cancer Institute 

Arnold H. Zea, PhD
Louisiana State University, Health Science Center

           

 

*Holbrook Edwin Kidd Kohrt, MD, PhD (1977-2016)
Dr. Kohrt had a significant impact on the field and brought his considerable scientific insights and incredible energy to every project. He was committed to the field of tumor immunology and immunotherapy and to the mission of SITC.